Daniel J George

32PUBLICATIONS
263CO-AUTHORS
Predictive and prognostic markersContaminant hydrologyRadiation therapyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Oct 13, 2026
Real-World Overall Survival With Abiraterone Acetate and Enzalutamide in Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer From the Flatiron Electronic Health Records Database.

|Sep 28, 2026
Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.

|Jul 28, 2026
3beta-HSD1-mediated steroid back-conversion maintains androgen signaling in prostate cancer.

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Jul 13, 2026
Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes.

|May 26, 2026
Genetic ancestry-concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer.

Pageof 6

Frequent Collaborators

6 joint publications

Andrew J Armstrong

5 joint publications

Emmanuel S Antonarakis

5 joint publications

Tian Zhang

5 joint publications

Pedro C Barata